Colon Cancer-Associated Transcripts 1 and 2: Roles and functions in human cancers.
CCAT1
CCAT2
cancer
lncRNA
Journal
Journal of cellular physiology
ISSN: 1097-4652
Titre abrégé: J Cell Physiol
Pays: United States
ID NLM: 0050222
Informations de publication
Date de publication:
Sep 2019
Sep 2019
Historique:
received:
21
11
2018
accepted:
10
01
2019
pubmed:
30
1
2019
medline:
30
1
2019
entrez:
30
1
2019
Statut:
ppublish
Résumé
The long noncoding RNAs (lncRNAs) Colon Cancer-Associated Transcripts 1 and 2 (CCAT1 and CCAT2) are located in a recurrently amplified region in cancers. Their proximity with the Myc oncogene and their interactions with its promoter provided further evidence for their contribution in the tumorigenesis processes. Several cell line and clinical studies have shown upregulation of these lncRNAs in diverse malignancies. Moreover, some single nucleotide variants within these genes have been associated with cancer risk or therapeutic response in different populations. Besides, these two lncRNAs act as sponges for some tumor suppressor microRNAs (miRNAs), thus promoting cancer evolution. In the current study, we review recent literature about their expression level, interaction with cancer-related pathways, their role in determination of cell fate and their contribution in malignant phenotype characteristics. Taken together, the current literature shows that these lncRNAs are putative targets for design of novel treatment strategies. Moreover, their expression levels in biopsied samples, exosomes, and sera of patients might be applied as diagnostic biomarkers or markers for patient follow-up.
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
14581-14600Informations de copyright
© 2019 Wiley Periodicals, Inc.